Canine T‐Zone Lymphoma: Unique Immunophenotypic Features, Outcome, and Population Characteristics

por Seelig, D.M., Avery, P., Webb, T., Yoshimoto, J., Bromberek, J., Ehrhart, E.J., Avery, A.C.
Publicado 2014

Breed Distribution and Clinical Characteristics of B Cell Chronic Lymphocytic Leukemia in Dogs

por Bromberek, J.L., Rout, E.D., Agnew, M.R., Yoshimoto, J., Morley, P.S., Avery, A.C.
Publicado 2016

Flow Cytometric Characterization and Clinical Outcome of CD4+ T‐Cell Lymphoma in Dogs: 67 Cases

por Avery, P.R., Burton, J., Bromberek, J.L., Seelig, D.M., Elmslie, R., Correa, S., Ehrhart, E.J., Morley, P.S., Avery, A.C.
Publicado 2014

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs

por Burton, J.H., Venable, R.O., Vail, D.M., Williams, L.E., Clifford, C.A., Axiak‐Bechtel, S.M., Avery, A.C., Thamm, D.H.
Publicado 2015

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

por Weishaar, K.M., Ehrhart, E.J., Avery, A.C., Charles, J.B., Elmslie, R.E., Vail, D.M., London, C.A., Clifford, C.A., Eickhoff, J.C., Thamm, D.H.
Publicado 2017